Skip to main content
Premium Trial:

Request an Annual Quote

Spotfire Recruits Ladd to Lead New Work Group

Premium

CAMBRIDGE, Mass.--Spotfire has recruited William Ladd as director of bioinformatics to lead its new Bioinformatics Rapid-Application-Development group, an interdisciplinary team of computer science, biology, chemistry, and statistics specialists based here. The group will work with pharmaceutical and biotech customers to develop technical decision support systems based on Spotfire's core product offerings. Solutions will target areas such as gene expression and clinical trials analysis, high-throughput screening, combinatorial chemistry, and pharmacogenomics. As evidence that this approach can be successful, the company pointed to its collaboration with DuPont Pharmaceuticals, which resulted in the launch of Spotfire Leads Discoverer, a system for managing and sharing screening and chemical structure information over the web. Before joining Spotfire, Ladd had been director of bioinformatics methods at Gene Logic, and, prior to that, spent over five years at Merck where he developed research applications for the company's discovery system.

Filed under

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.